Evaporative Dry Eye
12
0
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
33%
4 trials in Phase 3/4
50%
4 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Comparative Efficacy of Lipid Based Artificial Tears vs Aqueous Based Artificial Tears in Managing EDE
Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
Safety and Effectiveness of EyePeace on Signs and Symptoms of Dry Eye Disease
Tear Film Innovations iLux Safety Study
Impact of Tear Substitute Use on Dry Eye in Gamers.
Dextenza With ILUX for Treatment of MGD
Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
Quality of Life Improvement in Dry Eye Patients After Intense Pulsed Light Therapy Compared to Punctal Plugs
Comparison of Tear Evaporation Rate With DAILIES TOTAL1 and Biotrue ONEday
Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
iLux Treatment for Meibomian Gland Dysfunction (MGD)
Refractory Meibomian Gland Dysfunction and Plasma Jet